Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis
Previously, we demonstrated in test and validation cohorts that type I IFN (T1IFN) activity can predict non-response to tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA). In this study, we examine the biology of non-classical and classical monocytes from RA patients defined by the...
Main Authors: | Theresa L. Wampler Muskardin, Wei Fan, Zhongbo Jin, Mark A. Jensen, Jessica M. Dorschner, Yogita Ghodke-Puranik, Betty Dicke, Danielle Vsetecka, Kerry Wright, Thomas Mason, Scott Persellin, Clement J. Michet, John M. Davis, Eric Matteson, Timothy B. Niewold |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01384/full |
Similar Items
-
Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019
by: Theresa L. Wampler Muskardin
Published: (2020-05-01) -
Blau Syndrome: An Unusual Cause of Hypercalcemia in a Child
by: Hana Barbra Lo, MD, et al.
Published: (2018-07-01) -
Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
by: Uma Thanarajasingam, et al.
Published: (2019-10-01) -
Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation
by: Divya N. Challa, et al.
Published: (2017-09-01) -
JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review
by: Toshie Ogasawara, et al.
Published: (2020-01-01)